Femme et Homme
- | Pays :
- Belgium
- United States
- Spain
- Les 7 autres...
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to summarize the safety and tolerability of abatacept during 6 months of combined treatment with one or more of the background non-biologic disease modifying anti-rheumatic drugs (DMARDs) approved for rheumatoid arthritis (RA) in subjects with active RA. Secondary objectives assessed the clinical efficacy of combination treatment, including disease activity, physical function, and quality of life outcomes.
Critère d'inclusion
- Rheumatoid Arthritis